Research output per year
Research output per year
Personal profile
Public Profile
Biography:
Dr. Muneer Ahamed is a Senior Research Fellow and a National Imaging Facility (NIF) Fellow at SAHMRI, Adelaide. Dr. Ahamed has experience in industrial and academic research projects in CNS drug discovery, radiochemistry and neuro-imaging. Dr. Ahamed worked at GVK Bio and Jubilant Biosys Discovery Centre on CNS drug discovery. Dr. Ahamed has obtained PhD from The University of Sydney and received several awards during his PhD. He was awarded Le Fèvre postgraduate student lectureship, Agnes Campbell prize for excellence in organic chemistry and John R Lamberton award at The University of Sydney, besides the competitive University of Sydney International Postgraduate Scholarship. Inter-disciplinary post-doctoral positions at KU Leuven, Belgium and The University of Queensland on development of neuro-imaging probes for PET and new methods for radio-labelling. Dr. Ahamed has published 25 research articles and one granted patent in the field of neuroimaging, radiochemistry and medicinal chemistry.
Research Interest:
His research focuses on developing and translating new drugs and PET imaging agents for use in various brain-disorders. Validation of new neuro-PET tracers for imaging of various protein and enzyme targets in small and large animals. Current targets under investigation are the brain endocannabinoids, and particularly targets implicated in neuroinflammation, neurodegeneration and movement disorders.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Synthesis, isolation and characterisation of fluorinated-benzimidazoisoquinoline regioisomers
Lim, T. X., Pierens, G. K., Bernhardt, P. V., Ahamed, M. & Reutens, D. C., 2021, (Accepted/In press) In: Magnetic Resonance in Chemistry.Research output: Contribution to journal › Article › peer-review
-
The aryl hydrocarbon receptor: A diagnostic and therapeutic target in glioma
Lim, T. X., Ahamed, M. & Reutens, D. C., 2021, (Accepted/In press) In: Drug Discovery Today. 27, 2, p. 422-435 14 p.Research output: Contribution to journal › Review article › peer-review
-
Methods for Improved Low Temperature Fluorine-18 radiolabelling of Biomolecules
Syed Musthakahmed, M. A., 2020, Patent No. EP3212610B1Research output: Patent
-
Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: Effect on imatinib resistance and stem cells
Lernoux, M., Schnekenburger, M., Losson, H., Vermeulen, K., Hahn, H., Gérard, D., Lee, J. Y., Mazumder, A., Ahamed, M., Christov, C., Kim, D. W., Dicato, M., Bormans, G., Han, B. W. & Diederich, M., 19 May 2020, In: Clinical Epigenetics. 12, 1, 69.Research output: Contribution to journal › Article › peer-review
Open Access9 Citations (Scopus) -
Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications
Grimsey, N. L., Savinainen, J. R., Attili, B. & Ahamed, M., Feb 2020, In: Drug Discovery Today. 25, 2, p. 330-343 14 p.Research output: Contribution to journal › Review article › peer-review
8 Citations (Scopus)
Prizes
-
Agnes Campbell Prize for excellence in organic chemistry
Syed Musthakahmed, Muneer (Recipient), 2009
Prize
-
-
-
-
University of Sydney International Postgraduate Scholarship
Syed Musthakahmed, Muneer (Recipient), 2007
Prize